Triglyceride peroxidation progression in lipid droplets of hepatocytes in nonalcoholic steatohepatitis

Triglyceride peroxidation progression in lipid droplets of hepatocytes in nonalcoholic steatohepatitis

Objective: Nonalcoholic steatohepatitis is a chronic liver disease caused by the progression of hepatocellular death and inflammation from simple steatosis. However, the pathogenesis of this disease remains unclear. Lipid peroxidation is one of the most critical factors in the development of nonalco...

Full description

Bibliographic Details
Main Authors:	Kota Saito, Yuta Matsuoka, Masami Abe, Nao Kato, Kazushi Morimoto, Ken-ichi Yamada
Format:	Article
Language:	English
Published:	Bioscientifica 2024-02-01
Series:	Redox Experimental Medicine
Subjects:	nonalcoholic steatohepatitis lipid peroxidation oxidised triglycerides 4-hydroxy nonenal lipid droplet
Online Access:	https://rem.bioscientifica.com/view/journals/rem/2023/1/REM-22-0024.xml

Similar Items

Oxidative Stress Linked Organ Lipid Hydroperoxidation and Dysregulation in Mouse Model of Nonalcoholic Steatohepatitis: Revealed by Lipidomic Profiling of Liver and Kidney
by: Yue Wu, et al.
Published: (2021-10-01)

Potential Hepatic Lipid Markers Associated with Nonalcoholic Steatohepatitis and Fibrosis in Morbid Obesity Patients
by: Hua-Chien Wu, et al.
Published: (2023-05-01)

Circulating Levels of Pro-Neurotensin and Its Relationship with Nonalcoholic Steatohepatitis and Hepatic Lipid Metabolism
by: Beatriz Villar, et al.
Published: (2021-06-01)

Serum thymosin beta4 as a noninvasive biomarker in patients with nonalcoholic steatohepatitis
by: Yong Jiang, et al.

Heme oxygenase 1 alleviates nonalcoholic steatohepatitis by suppressing hepatic ferroptosis
by: Xiwei Yuan, et al.
Published: (2023-07-01)

Caspase-11–Mediated Hepatocytic Pyroptosis Promotes the Progression of Nonalcoholic SteatohepatitisSummary
by: Yingwei Zhu, et al.
Published: (2021-01-01)

Increased Hepatic <i>ATG7</i> mRNA and ATG7 Protein Expression in Nonalcoholic Steatohepatitis Associated with Obesity
by: Andrea Barrientos-Riosalido, et al.
Published: (2023-01-01)

Gamma-Muricholic Acid Inhibits Nonalcoholic Steatohepatitis: Abolishment of Steatosis-Dependent Peroxidative Impairment by FXR/SHP/LXRα/FASN Signaling
by: Yang Xie, et al.
Published: (2023-03-01)

Recent update: Nonalcoholic steatohepatitis
by: Vivek Hande, et al.
Published: (2018-01-01)

Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis
by: Mindy C.W. Lam, et al.
Published: (2012-07-01)

Convergence of the 5-LOX and COX-2 pathways: heme-catalyzed cleavage of the 5S-HETE-derived di-endoperoxide into aldehyde fragments
by: Markus Griesser, et al.
Published: (2009-12-01)

Disease Progression in a Patient with Nonalcoholic Steatohepatitis
by: Ping-Huei Tseng, et al.
Published: (2008-10-01)

Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiology
by: In Cheol Yoon, et al.
Published: (2019-05-01)

Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis
by: Seonghwan Hwang, et al.
Published: (2021-10-01)

Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitis
by: S.M. Touhidul Islam, et al.
Published: (2020-09-01)

Association between Equol Production Status and Nonalcoholic Steatohepatitis
by: Takemi Akahane, et al.
Published: (2021-11-01)

Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis
by: D.N. Amarapurkar, et al.
Published: (2006-01-01)

Angiogenesis in alcoholic steatohepatitis, nonalcoholic steatohepatitis and hepatitis C virus infection (immunohistochemical study)
by: Gavrilyuk O.M.
Published: (2013-12-01)

Sesamin ameliorates nonalcoholic steatohepatitis through inhibiting hepatocyte pyroptosis in vivo and in vitro
by: Teng Zhang, et al.
Published: (2024-02-01)

Taurine and tea polyphenols combination ameliorate nonalcoholic steatohepatitis in rats
by: Wenhua Zhu, et al.
Published: (2017-09-01)

Possible Development of Burn-Out Nonalcoholic Steatohepatitis under Long-Term Steroid Use
by: Soichiro Ota, et al.
Published: (2022-09-01)

Clinical and pathogenetic differences of the course of flow nonalcoholic steatohepatitis in obese patients with and without hypertension
by: O.S. Khukhlina, et al.
Published: (2013-08-01)

Nonalcoholic steatohepatitis: global impact and clinical consequences
by: Khaled Kabarra, et al.
Published: (2021-10-01)

Drug discovery and treatment paradigms in nonalcoholic steatohepatitis
by: Mazen Noureddin, et al.
Published: (2020-10-01)

Improved hepatic γ-tocopherol status limits oxidative and inflammatory stress-mediated liver injury in db/db mice with nonalcoholic steatohepatitis
by: Priyankar Dey, et al.
Published: (2018-01-01)

Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat[S]
by: Hua Zhang, et al.
Published: (2013-02-01)

Loss of Splicing Factor SRSF3 Impairs Lipophagy Through Ubiquitination and Degradation of Syntaxin17 in Hepatocytes
by: Yun Li, et al.
Published: (2023-03-01)

Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients
by: Haghpanah Babak, et al.
Published: (2003-10-01)

Nonalcoholic steatohepatitis and biliary sludge in people with metabolic syndrome
by: V G Radchenko, et al.
Published: (2016-09-01)

Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
by: Bing Yang, et al.
Published: (2022-09-01)

Icariin Supplementation Suppresses the Markers of Ferroptosis and Attenuates the Progression of Nonalcoholic Steatohepatitis in Mice Fed a Methionine Choline-Deficient Diet
by: Jiwon Choi, et al.
Published: (2023-08-01)

Corrigendum: Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
by: Bing Yang, et al.
Published: (2023-09-01)

Angiogenic effects of leptin in patients with nonalcoholic steatohepatitis
by: Gaafar Nagah, et al.
Published: (2005-01-01)

White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in MiceSummary
by: Sadatsugu Sakane, et al.
Published: (2021-01-01)

Корекція ендотоксикозу і синдрому пероксидації у хворих на подагру в поєднанні з неалкогольним стеатогепатитом = Lipid peroxidation and endotoxemia syndrome сorrection in patients with gout combined with nonalcoholic steatohepatitis
by: S. I. Smiyan, et al.
Published: (2015-10-01)

Корекція ендотоксикозу і синдрому пероксидації у хворих на подагру в поєднанні з неалкогольним стеатогепатитом = Lipid peroxidation and endotoxemia syndrome сorrection in patients with gout combined with nonalcoholic steatohepatitis
by: S. I. Smiyan, et al.
Published: (2015-10-01)

Functional interaction between cyclooxygenase-2 and p53 in response to an endogenous electrophile
by: Takeshi Kumagai, et al.
Published: (2015-04-01)

Possibilities of correction of lipid-phospholipid disorders in patients with non-alcoholic steatohepatitis against obesity and pathology of the biliary tract.
by: A. Yu. Filippova
Published: (2019-11-01)

A simple method for inducing nonalcoholic steatohepatitis with fibrosis
by: Leyla Yahaghi, et al.
Published: (2019-12-01)

The Influence of Pathogenetic Treatment on Peroxidation in Patients with Ischemic Heart Disease and Comorbid Nonalcoholic Steatohepatitis
by: Skrypnyk I., et al.
Published: (2017-12-01)